Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT04643145
Collaborator
(none)
130
1
2
33.5
3.9

Study Details

Study Description

Brief Summary

Flexible ureterorenoscopy (FURS) is now recommended for the treatment of kidney stones smaller than 20 mm, as an alternative to extracorporeal shock wave lithotripsy (ESWL) and in combination with percutanous nephrolithotomy (PCNL) for stones larger than 20 mm. At the end of the operation, a ureteral drainage is put in place for the treatment of residual fragments and the inflammation following the ureteroscopy. It helps prevent obstructive symptoms and the development of strictures.

Drainage is done either by a ureteral catheter or by a double J stent. In the literature, while drainage after ureteroscopy is recommended, the criteria for choosing between these two options are not clearly defined.

The objective of this study will be to assess whether the type of postoperative drainage after URS for kidney stones can influence the perioperative outcomes and health-related quality of life.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Flexible ureteroscopy for renal calculi less than 20 mm
N/A

Detailed Description

Flexible ureterorenoscopy (FURS) is now recommended for the treatment of kidney stones smaller than 20 mm, as an alternative to extracorporeal shock wave lithotripsy (ESWL) and in combination with percutanous nephrolithotomy (PCNL) for stones larger than 20 mm. At the end of the operation, a ureteral drainage is put in place for the treatment of residual fragments and the inflammation following the ureteroscopy. It helps prevent obstructive symptoms and the development of strictures.

Drainage is done either by a ureteral catheter or by a double J stent. In the literature, while drainage after ureteroscopy is recommended, the criteria for choosing between these two options are not clearly defined.

The objective of this study will be to assess whether the type of postoperative drainage after URS for kidney stones can influence the perioperative outcomes and health-related quality of life.

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial
Actual Study Start Date :
Mar 1, 2018
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Dec 15, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Ureteral catheter

This group will receive ureteral catheter for 2 days after the procedure

Procedure: Flexible ureteroscopy for renal calculi less than 20 mm
Patients with renal calculi less than 20 mm will be managed by flexible ureteroscopy. at the end of the procedure, they will be randomized to receive either temporary ureteral catheter for 2 days or indweeling double J stent for 2-4 weeks

Active Comparator: Indwelling double J stent

This group will receive indwelling double J stent for 2-4 weeks after the procedure

Procedure: Flexible ureteroscopy for renal calculi less than 20 mm
Patients with renal calculi less than 20 mm will be managed by flexible ureteroscopy. at the end of the procedure, they will be randomized to receive either temporary ureteral catheter for 2 days or indweeling double J stent for 2-4 weeks

Outcome Measures

Primary Outcome Measures

  1. Stone free rate [12 weeks after the procedure]

    presence of residual fragments on non contrast computed tomography

Secondary Outcome Measures

  1. perioperative complications [First 3 days postoperative]

    perioperative complications after the procedure

  2. Postoperative pain by visual analogue scale [first 24 hours postoperatively]

    Visual analogue scale will be assessed postoperative

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 1- Adult patients (aged >18 years) 2- Undergo unilateral uncomplicated retrograde intrarenal surgery (RIRS) using flexible ureterorenoscopy.
Exclusion Criteria:
  1. Residual ureteral or renal stones after the procedure as documented by the surgeon

  2. Patients who will need auxiliary procedures (ESWL , re-FURS or PCNL)

  3. Preoperative febrile UTI

  4. pregnancy or breastfeeding

  5. Bilateral ureteroscopic surgery

  6. Single kidney

  7. Chronic kidney disease

  8. Cardiovascular or cerebrovascular disease

  9. Hepatic dysfunction

  10. Other acute medical conditions as acute gastroenteritis, osetoarthritis that might influence the patient QoL

Contacts and Locations

Locations

Site City State Country Postal Code
1 Urology and Nephrology Center Mansoura DK Egypt 35516

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Principal Investigator: Amr A Elsawy, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amr Abdel-Lateif El-Sawy, Principal Investigator, Mansoura University
ClinicalTrials.gov Identifier:
NCT04643145
Other Study ID Numbers:
  • AE 201121
First Posted:
Nov 24, 2020
Last Update Posted:
Jan 22, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Amr Abdel-Lateif El-Sawy, Principal Investigator, Mansoura University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 22, 2021